Newsletters
- Bay Area Newsletter
- Greater Los Angeles Newsletter
- Group Purchasing Newsletter
- Public Policy Newsletter
- Regulatory & Reimbursement Newsletter
- San Diego Newsletter
Home / Newsletters / Regulatory & Reimbursement Newsletter

FDA reveals FY26 budget, plans to expand unannounced foreign inspections, increase the use of AI in its scientific reviews and enhance state drug importation programs, and more.

HHS is undergoing a large-scale reorganization, the FDA has announced a phase-out of animal testing requirements and more.